The Influence of Blood Sampling Technique on the Total Amount of Blood Collected for Laboratory Testing Critically Ill Pediatric Patients
- Conditions
- Iatrogenic Anaemia
- Registration Number
- NCT06376747
- Lead Sponsor
- Brno University Hospital
- Brief Summary
The aim of this prospective randomized study is to evaluate blood loss caused by laboratory blood draws in patients in the paediatric ICU (Intensive Care Unit) of a tertiary hospital among two groups of patients with established long-term or mid-term intravenous access. In the first group, patients will undergo blood draws using the standard method. In the second group of patients, blood draws will be performed using a closed system.
- Detailed Description
Anaemia is one of the most common comorbidities among patients hospitalized in intensive care units. Hospital-acquired anaemia (HAA) is a newly developed anaemia that occurs during hospitalization in patients who were not anaemic prior to admission. Patients with HAA have a higher risk of developing complications such as infections, muscle weakness, and neurocognitive developmental disorders; an increased incidence of blood and blood product transfusions (and related complications); longer hospital stays, and higher morbidity and mortality. According to available data, the incidence of anaemia in adults hospitalized in the ICU ranges from 40 to 74%. There a feq data describing anemia in critically ill pediatric patients, with the estimated incidence being up to 50%.
The etiology of HAA is multifactorial and is related to the severity of the underlying disease (sepsis, coagulation disorders, bleeding, renal failure, malnutrition, bone marrow suppression, decreased erythropoietin production, etc.). Another factor contributing to the development of anaemia in critically ill patients is iatrogenic blood loss caused by blood draws for laboratory testing.
In addition to the standard blood collection method, closed-loop sampling (in-line sampling) can also be used, with studies in adult patients showing a reduction in the amount of blood drawn, ranging from 20 to 80% after its implementation.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Signed informed consent for the study.
- Patients with established intravenous access: CVC (Central Venous Catheter), CICC (Centrally Inserted Central Catheter), PICC (Peripherally Inserted Central Catheter), MVC (Midline Venous Catheter), venous port, from which blood can be drawn.
- Anticipated length of stay in the ICU more than 24 hours
- Age outside the specified range.
- Peripheral venous access only.
- Anticipated length of stay in the ICU less than 24 hours.
- Organ donors.
- Lack of consent from the legal representative/patient.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Average amount of blood collected for laboratory diagnostic purposes On day 1,3,5,7,10,14 and 28 of patient stay at paediatric ICU Average amount of blood collected for laboratory diagnostic purposes on days 1, 3, 5, 7, 10, 14, and 28 of hospitalization in two groups of patients subjected to different blood sampling techniques for laboratory testing
- Secondary Outcome Measures
Name Time Method Incidence of anaemia up to transfusion trigger on the day of patient' s discharge from paediatric ICU haemoglobin levels below 70 g/l at any time during hospitalization
Trend of haemoglobin decline over time Ondays 1,3,5,7,10,14 and 28 of patient stay at paediatric ICU Trend of haemoglobin decline over time, defined as the absolute value of haemoglobin
Incidence of anaemia on the day of patient' s discharge from paediatric ICU decrease in haemoglobin levels below 90 g/l at any time during hospitalization
Frequency of blood product transfusions and their quantity on the day of patient' s discharge from paediatric ICU Frequency of blood product transfusions (erythrocytes, platelets, plasma, fibrinogen, and other coagulation factors) and their quantity relative to the patient's body weight and age
Absolute amount of blood drawn and blood used for laboratory testing On the day of patient' s discharge from paediatric ICU Absolute amount of blood drawn and blood used for laboratory testing, relative to the patient's body weight, age, and day of ICU hospitalization
Incidence of coagulopathy on the day of patient' s discharge from paediatric ICU Incidence of coagulopathy defined as INR above 1.4 and/or aPTT above 1.5 and/or fibrinogen below 1.5 g/l
Incidence of catheter-related complications on the day of patient' s discharge from paediatric ICU Incidence of catheter-related complications catheter infections, catheter occlusion defined, accidental catheter withdrawal)
Cumulative amount of blood drawn per day of ICU hospitalization On the day of patient' s discharge from paediatric ICU Cumulative amount of blood drawn, relative to the patient's body weight and age, per day of ICU hospitalization
Type and frequency of laboratory tests on the day of patient' s discharge from paediatric ICU Type and frequency of laboratory tests noted on daily basis by ICU nursing stuff
Time to catheter replacement in case of catheter exchange on the day of patient' s discharge from paediatric ICU Time to catheter replacement in case of catheter exchange (in days)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
KDAR - department of pediatrics anesthesia and resuscitation
🇨🇿Brno, Czechia
KDAR - department of pediatrics anesthesia and resuscitation🇨🇿Brno, Czechia